跳转至内容
Merck
  • A basis for vaccine development: Comparative characterization of Haemophilus influenzae outer membrane vesicles.

A basis for vaccine development: Comparative characterization of Haemophilus influenzae outer membrane vesicles.

International journal of medical microbiology : IJMM (2015-01-17)
Sandro Roier, Thomas Blume, Lisa Klug, Gabriel E Wagner, Wael Elhenawy, Klaus Zangger, Ruth Prassl, Joachim Reidl, Günther Daum, Mario F Feldman, Stefan Schild
摘要

Outer membrane vesicles (OMVs) are spherical and bilayered particles that are naturally released from the outer membrane (OM) of Gram-negative bacteria. They have been proposed to possess several biological roles in pathogenesis and interbacterial interactions. Additionally, OMVs have been suggested as potential vaccine candidates against infections caused by pathogenic bacteria like Haemophilus influenzae, a human pathogen of the respiratory tract. Unfortunately, there is still a lack of fundamental knowledge regarding OMV biogenesis, protein sorting into OMVs, OMV size and quantity, as well as OMV composition in H. influenzae. Thus, this study comprehensively characterized and compared OMVs and OMs derived from heterologous encapsulated as well as nonencapsulated H. influenzae strains. Semiquantitative immunoblot analysis revealed that certain OM proteins are enriched or excluded in OMVs suggesting the presence of regulated protein sorting mechanisms into OMVs as well as interconnected OMV biogenesis mechanisms in H. influenzae. Nanoparticle tracking analysis, transmission electron microscopy, as well as protein and lipooligosaccharide quantifications demonstrated that heterologous H. influenzae strains differ in their OMV size and quantity. Lipidomic analyses identified palmitic acid as the most abundant fatty acid, while phosphatidylethanolamine was found to be the most dominant phospholipid present in OMVs and the OM of all strains tested. Proteomic analysis confirmed that H. influenzae OMVs contain vaccine candidate proteins as well as important virulence factors. These findings contribute to the understanding of OMV biogenesis as well as biological roles of OMVs and, in addition, may be important for the future development of OMV based vaccines against H. influenzae infections.

材料
货号
品牌
产品描述

Sigma-Aldrich
二甲基亚砜, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
Sigma-Aldrich
二甲基亚砜, for molecular biology
Sigma-Aldrich
二甲基亚砜, sterile-filtered, BioPerformance Certified, meets EP, USP testing specifications, suitable for hybridoma
Sigma-Aldrich
十二烷基硫酸钠, BioReagent, suitable for electrophoresis, for molecular biology, ≥98.5% (GC)
Sigma-Aldrich
蔗糖, for molecular biology, ≥99.5% (GC)
Sigma-Aldrich
蔗糖, ≥99.5% (GC)
Sigma-Aldrich
二甲基亚砜, ≥99.5% (GC), suitable for plant cell culture
Sigma-Aldrich
氢氧化钠 溶液, BioUltra, for molecular biology, 10 M in H2O
Sigma-Aldrich
DL-二硫代苏糖醇 溶液, BioUltra, for molecular biology, ~1 M in H2O
Sigma-Aldrich
十二烷基硫酸钠, ≥99.0% (GC), dust-free pellets
Sigma-Aldrich
蔗糖, ≥99.5% (GC), BioXtra
Sigma-Aldrich
碘乙酰胺, BioUltra
Sigma-Aldrich
碘乙酰胺, Single use vial of 56 mg
Supelco
DL-二硫代苏糖醇 溶液, 1 M in H2O
Sigma-Aldrich
蔗糖, BioUltra, for molecular biology, ≥99.5% (HPLC)
Sigma-Aldrich
2 mol/L 氢氧化钠溶液 溶液, 1.0 N, BioReagent, suitable for cell culture
Sigma-Aldrich
十二烷基硫酸钠 溶液, BioUltra, for molecular biology, 10% in H2O
Sigma-Aldrich
二甲基亚砜, anhydrous, ≥99.9%
Sigma-Aldrich
碘乙酰胺, ≥99% (NMR), crystalline
Sigma-Aldrich
十二烷基硫酸钠 溶液, BioUltra, for molecular biology, 20% in H2O
Sigma-Aldrich
二甲基亚砜, BioUltra, for molecular biology, ≥99.5% (GC)
Sigma-Aldrich
p -香豆酸, ≥98.0% (HPLC)
Sigma-Aldrich
氢氧化钠 溶液, 0.1 M
Sigma-Aldrich
蔗糖, ≥99.5% (GC), BioReagent, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
十二烷基硫酸钠, BioUltra, for molecular biology, ≥99.0% (GC)
Sigma-Aldrich
蔗糖, ≥99.5% (GC)
Sigma-Aldrich
鲁米诺, 97%
Sigma-Aldrich
十二烷基硫酸钠, ACS reagent, ≥99.0%
Sigma-Aldrich
氢氧化钠 溶液, 1 M
Sigma-Aldrich
蔗糖, ≥99.5% (GC), Grade II, suitable for plant cell culture